Back to results
CompletedPhase 1

A Study of MK-4700 Alone or With Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors (MK-4700-001)

NCT06894771

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

John Theurer Cancer Center at Hackensack University Medical Center ( Site 0301)

Hackensack, New Jersey, United States

+6 additional locations

View on ClinicalTrials.gov
A Study of MK-4700 Alone or With Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors (MK-4700-001) — TrialFind